We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for isatuximab (Sanofi-Aventis Australia Pty Ltd)
Active ingredients
isatuximab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Concentrated injection
Indication
The treatment of plasma cell myeloma.
Therapeutic area
Haematology